Worldwide Clinical Trials Brochures
-
Rare Meets Real
1/19/2022
Worldwide Clinical Trials is uniquely experienced in the design and execution of rare disease research initiatives that embrace the evolving need for real-world evidence at all points along the drug development and commercialization continuum.
-
Worldwide Clinical Trials’ Early Phase Services
4/13/2021
As an early phase contract research organization (CRO), we offer a range of services executed by professionals fully dedicated to your early development program.
-
Is Your CRO The Right Fit For Your Rare Or Orphan Disease Trial?
2/24/2021
Biotech and pharmaceutical companies need a CRO with exceptional clinical trial expertise in the rare disease space, with the agility and flexibility needed to ensure patients’ needs come first. Our experience working with research networks, pediatric hospitals, specialized treatment centers, and academic institutions benefits your rare disease program. We connect with patient organizations and enlist key opinion leaders around the world to assist in the vetting of protocol designs, site identification, and patient recruitment.
-
Flawlessly Execute Your Cardiovascular And Metabolic Clinical Trials
2/10/2021
In the evolving cardiovascular research space, deep medical and scientific expertise, proven agility, and integrated technology conducted in an unwavering collaborative partnership are the minimum requirements for success, regardless of trial size or indication. With so much at stake, you want a CRO partner you can trust to successfully manage the many moving parts of your cardiovascular trial. See what qualifies us to be your partner.
-
Full-Service Fit-For-Purpose Clinical Pharmacology Research Unit
1/18/2021
Your early phase program needs a clinical pharmacology unit (CPU) that’s renowned for its services, staff, and accessibility. Worldwide Clinical Trials has been top-ranked by its early phase customers for these qualities in the latest Early Phase CRO Quality Benchmarking Report by Industry Standard Research, making it the “go-to” CRO for your early phase program.
-
Worldwide Clinical Trials' Bioanalytical Laboratory
10/14/2020
We deliver uncommon value. From discovery to post-marketing, we partner with your team to develop a custom method, transfer/optimize and validate an existing method, identify liabilities and de-risk a regulated assay, or adapt a method to increase efficiency and cost-effectiveness.
-
The CNS Challenge: Balancing Risk With Reward
9/10/2020
Founded by a team of neuroscientists, Worldwide has worked in CNS since the late 1970s when the first cholinesterase inhibitors emerged as a cognitive therapeutic. Our breadth and depth of experience continues more than 40 years later, as we continue to innovate and adapt in our commitment to advancing research.
-
Moving Multiple Sclerosis Trials Forward, Faster
7/27/2020
Your CRO partner can have a significant impact on the success or failure of your clinical study and program. As a full-service CRO, Worldwide Clinical Trials has an outstanding track record in starting up and executing MS studies, including beta-interferons, glatiramer acetate monoclonal antibodies, and oral preparations for disease-modifying approaches.
-
How To Transform Your Immune-Mediated Inflammatory Disorder Clinical Program
7/27/2020
Our team combines knowledge about inflammatory processes, clinical manifestations, and therapeutic targets with deep operational expertise in the challenges associated with advanced clinical research in this complex and crowded field.
-
6 Ways To Overcome Challenges In Early-Phase Oncology Trials
7/24/2020
By proactively working to avoid the common roadblocks in early-phase oncology trials—and bringing in trial planning and administration experts to lay out an optimal strategy for your drug development program—you can give your drug the best possible chance at success.